The impact of ExHp-CD (outer membrane vesicles) released from Helicobacter pylori SS1 on macrophage RAW 264.7 cells

Abeer Ahmed Qaed Ahmed1, Fuyu Qi1, Ruizhu Zheng1

  • 1Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan 430074, China.

Life Sciences
|May 28, 2021
PubMed

Insights

Bacterial outer membrane vesicles (ExHp-CD) from Helicobacter pylori induce a beneficial T helper 2 immune response, showing promise for treating infections. ExHp-CD demonstrated superior safety and biocompatibility compared to total antigens.

Area of Science:

  • Immunology
  • Microbiology
  • Biotechnology

Background:

  • Bacterial extracellular vesicles (EVs) are crucial for modulating immune responses and combating infections.
  • Helicobacter pylori (H. pylori) infection is a significant global health concern.
  • Understanding the immunogenic potential of H. pylori-derived EVs is vital for developing novel therapeutic strategies.

Purpose of the Study:

  • To evaluate the immunogenic potential of outer membrane vesicles (ExHp-CD) from H. pylori SS1 and total antigens (AgHp).
  • To assess the effects of ExHp-CD on macrophage RAW 264.7 cells.
  • To identify the specific components within ExHp-CD responsible for its immunogenic activity.

Main Methods:

  • Isolation and characterization of outer membrane vesicles (ExHp-CD) and total antigens (AgHp) from H. pylori SS1.
  • Assessment of immune response by measuring cytokine production (IL-10, IL-4, IL-12 p70, IFN-γ).
  • Evaluation of macrophage activation markers (CD206, CD86) following stimulation with ExHp-CD.

Main Results:

  • Both ExHp-CD and AgHp induced a T helper 2 (Th2) immune response, characterized by high levels of IL-10 and IL-4.
  • ExHp-CD demonstrated a more favorable effect on macrophage RAW 264.7 cells, promoting an M2 phenotype (CD206+) and reducing M1 markers (CD86+).
  • The immunogenic properties of ExHp-CD were linked to its cargo proteins: Epimerase_2 domain-containing protein (Epi_2D), Probable malate:quinone oxidoreductase (Pro_mqo), and Probable cytosol aminopeptidase (Pro_ca).

Conclusions:

  • ExHp-CD exhibits significant immunological activity, inducing a Th2 immune response against H. pylori infection, comparable to total antigens.
  • ExHp-CD possesses superior safety, biocompatibility, and hemocompatibility profiles.
  • ExHp-CD represents a promising immunogenic candidate for therapeutic applications against H. pylori infections.